Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Dickinson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Neuropharmacology|July 15, 2025
Bálint Syndrome From Posterior Cerebral Artery Infarctions Case ReportLuke Leidy, Anna Dickinson
Aging & Mental Health|August 30, 2008
Promoting older adults' well-being through Internet training and use. Response to Shapira et alAnna Dickinson, Peter Gregor
Survey of Ophthalmology|March 14, 2024
Clinical outcome measures in vision and eye careLuke Leidy, Anna Dickinson, Pradeep Ramulu, et al.
Molecular Plant-Microbe Interactions : MPMI|February 9, 2026
The Five Senses: How Do Plant Pathogens Know They Found Their Host?Rachel Hammond, Anna Dickinson, Anika Damm, et al.
Journal of Glaucoma|March 3, 2025
Treatment Outcomes of Micropulse Transscleral Laser Therapy as an Adjunctive Therapy in African American Individuals With Prior Procedural InterventionsAnna Dickinson, Luke Leidy, Jella An, et al.
International Journal of Molecular Sciences|July 13, 2024
Targeting Macrophage Polarization for Reinstating Homeostasis following Tissue DamageQiran Du, Anna Dickinson, Pruthvi Nakuleswaran, et al.
Journal of Glaucoma|April 8, 2026
One-Year Efficacy of OMNI Canaloplasty With and Without Additional Hydrus Microstent During Cataract SurgeryMadeline C Rocks, Jason Dossantos, Hoang-Viet Tran, et al.
Journal of Glaucoma|June 13, 2023
Short-Term Outcomes of Hydrus Microstent With and Without Additional Canaloplasty During Cataract SurgeryAnna Dickinson, Luke Leidy, Omar Nusair, et al.
Medicine|November 28, 2023
Prediction of MIGS outcomes on second eyes using first eyes' responseAnna Dickinson, Luke Leidy, Omar Nusair, et al.
Journal for Immunotherapy of Cancer|January 22, 2021
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63)Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Neuropharmacology|July 15, 2025
Bálint Syndrome From Posterior Cerebral Artery Infarctions Case ReportLuke Leidy, Anna Dickinson
Aging & Mental Health|August 30, 2008
Promoting older adults' well-being through Internet training and use. Response to Shapira et alAnna Dickinson, Peter Gregor
Survey of Ophthalmology|March 14, 2024
Clinical outcome measures in vision and eye careLuke Leidy, Anna Dickinson, Pradeep Ramulu, et al.
Molecular Plant-Microbe Interactions : MPMI|February 9, 2026
The Five Senses: How Do Plant Pathogens Know They Found Their Host?Rachel Hammond, Anna Dickinson, Anika Damm, et al.
Journal of Glaucoma|March 3, 2025
Treatment Outcomes of Micropulse Transscleral Laser Therapy as an Adjunctive Therapy in African American Individuals With Prior Procedural InterventionsAnna Dickinson, Luke Leidy, Jella An, et al.
International Journal of Molecular Sciences|July 13, 2024
Targeting Macrophage Polarization for Reinstating Homeostasis following Tissue DamageQiran Du, Anna Dickinson, Pruthvi Nakuleswaran, et al.
Journal of Glaucoma|April 8, 2026
One-Year Efficacy of OMNI Canaloplasty With and Without Additional Hydrus Microstent During Cataract SurgeryMadeline C Rocks, Jason Dossantos, Hoang-Viet Tran, et al.
Journal of Glaucoma|June 13, 2023
Short-Term Outcomes of Hydrus Microstent With and Without Additional Canaloplasty During Cataract SurgeryAnna Dickinson, Luke Leidy, Omar Nusair, et al.
Medicine|November 28, 2023
Prediction of MIGS outcomes on second eyes using first eyes' responseAnna Dickinson, Luke Leidy, Omar Nusair, et al.
Journal for Immunotherapy of Cancer|January 22, 2021
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63)Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Pageof 2